Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahar M El-Haggar

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Endocrine|December 26, 2014
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative studySahar M El-Haggar, Tarek M Mostafa
Journal of Diabetes and Its Complications|February 24, 2015
Effect of ketotifen in obese patients with type 2 diabetes mellitusSahar M El-Haggar, Wael F Farrag, Fedaa A Kotkata
Diabetes & Metabolic Syndrome|January 16, 2019
Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patientsHadier M El-Sheikh, Sahar M El-Haggar, Tamer A Elbedewy
Molecular Neurobiology|July 31, 2025
Pentoxifylline as Adjuvant Therapy in Patients with Generalized Epilepsy Treated with Phenytoin: A Randomized Controlled StudyMaha A Younis, Sahar M El-Haggar, Wessam Mustafa, et al.
Inflammopharmacology|September 28, 2024
Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot studyMohannad O Khrieba, Sahar K Hegazy, Wessam Mustafa, et al.
Inflammopharmacology|May 30, 2026
Metformin repurposing in gout: enhancing febuxostat efficacy through anti-inflammatory and metabolic modulation: a randomized controlled double-blind studyDalia N Abdel-Sadek, Tarek M Abd-Elazez, Sahar M El-Haggar
Inflammopharmacology|January 9, 2025
A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapySahar M El-Haggar, Dina S Attalla, Mostafa Elhelbawy, et al.
Journal of Diabetes and Its Complications|September 14, 2025
Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trialMaryam A Rizk, Sahar M El-Haggar, Osama M Ibrahim, et al.
Pharmacotherapy|February 16, 2026
Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug-Resistant Epilepsy: A Double-Blind Placebo-Controlled TrialAmira R Rashdan, Sahar M El-Haggar, Ahmed Mustafa Kishk, et al.
International Immunopharmacology|April 20, 2025
Clinical study to investigate the adjuvant role of Pentoxifylline in patients with Parkinson's disease: A randomized controlled studyMohannad O Khrieba, Sahar K Hegazy, Wessam Fathi Mohammed, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Endocrine|December 26, 2014
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative studySahar M El-Haggar, Tarek M Mostafa
Journal of Diabetes and Its Complications|February 24, 2015
Effect of ketotifen in obese patients with type 2 diabetes mellitusSahar M El-Haggar, Wael F Farrag, Fedaa A Kotkata
Diabetes & Metabolic Syndrome|January 16, 2019
Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patientsHadier M El-Sheikh, Sahar M El-Haggar, Tamer A Elbedewy
Molecular Neurobiology|July 31, 2025
Pentoxifylline as Adjuvant Therapy in Patients with Generalized Epilepsy Treated with Phenytoin: A Randomized Controlled StudyMaha A Younis, Sahar M El-Haggar, Wessam Mustafa, et al.
Inflammopharmacology|September 28, 2024
Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot studyMohannad O Khrieba, Sahar K Hegazy, Wessam Mustafa, et al.
Inflammopharmacology|May 30, 2026
Metformin repurposing in gout: enhancing febuxostat efficacy through anti-inflammatory and metabolic modulation: a randomized controlled double-blind studyDalia N Abdel-Sadek, Tarek M Abd-Elazez, Sahar M El-Haggar
Inflammopharmacology|January 9, 2025
A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapySahar M El-Haggar, Dina S Attalla, Mostafa Elhelbawy, et al.
Journal of Diabetes and Its Complications|September 14, 2025
Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trialMaryam A Rizk, Sahar M El-Haggar, Osama M Ibrahim, et al.
Pharmacotherapy|February 16, 2026
Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug-Resistant Epilepsy: A Double-Blind Placebo-Controlled TrialAmira R Rashdan, Sahar M El-Haggar, Ahmed Mustafa Kishk, et al.
International Immunopharmacology|April 20, 2025
Clinical study to investigate the adjuvant role of Pentoxifylline in patients with Parkinson's disease: A randomized controlled studyMohannad O Khrieba, Sahar K Hegazy, Wessam Fathi Mohammed, et al.
Pageof 3